Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
ETFs with BLUE as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|0.75%||iShares Morningstar Small-Cap Growth ETF (JKK)||+12.79 (8.39%)|
|0.29%||PowerShares DWA SmallCap Momentum Portfolio (DWAS)||+3.16 (7.73%)|
|0.27%||iShares Russell 2000 Value ETF (IWN)||-0.12 (-0.10%)|
|0.22%||iShares Russell 2000 ETF (IWM)||+4.71 (3.42%)|
|0.21%||SPDR Russell 2000 ETF (TWOK)||+2.91 (3.57%)|
Company Description (as filed with the SEC)
We are a clinical-stage biotechnology company committed to developing potentially transformative gene therapies for severe genetic diseases and cancer. With our lentiviral-based gene therapy and gene editing capabilities, we have built an integrated product platform with broad potential application in these areas. We believe that gene therapy for severe genetic diseases has the potential to change the way these patients are treated by correcting the underlying genetic defect that is the cause of their disease, rather than offering treatments that only address their symptoms. Our clinical programs in severe genetic diseases include our LentiGlobin® product candidate to treat transfusion-dependent ?-thalassemia, or TDT, and to treat severe sickle cell disease, or severe SCD, and our Lenti-D(TM) product candidate to treat cerebral adrenoleukodystrophy, or CALD. ... More ...
Where does BLUE fit in the risk graph?